 | Up a level |
Hermann, Dirk M; Bassetti, Claudio L; Marx, Ute; Audoli-Inthavong, Marie-Laure; Chabriat, Hugues (2020). Refining endpoints for stroke recovery trials. The lancet. Neurology, 19(5), pp. 381-382. Elsevier 10.1016/S1474-4422(20)30101-0
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Audoli-Inthavong, Marie-Laure; Sors, Aurore; Lambert, Estelle; Wattez, Marine; Hermann, Dirk M (2020). Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial. The lancet. Neurology, 19(3), pp. 226-233. Elsevier 10.1016/S1474-4422(20)30004-1
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Picarel-Blanchot, Françoise; Sors, Aurore; Gruget, Celine; Saba, Barbara; Wattez, Marine; Audoli, Marie-Laure; Hermann, Dirk M. (2020). Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study. Trials, 21(1), p. 136. BioMed Central 10.1186/s13063-020-4072-2
